The use of immunotherapy to treat metastatic breast cancer – EurekAlert (press release)
|
The use of immunotherapy to treat metastatic breast cancer
EurekAlert (press release) Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harbouring the expression of HER 2 receptor. Particularly in HER 2 positive patients pertuzumab plus trastuzumab and docetaxel is the recommended first … |
